XML 131 R1.htm IDEA: XBRL DOCUMENT v3.24.2
Document And Entity Information
 3 Months Ended
Mar. 31, 2024
Document Information Line Items  
Entity Registrant Name ABVC BIOPHARMA, INC.
Document Type POS AM
Amendment Flag true
Amendment Description This Post-Effective Amendment No. 5 (this “Post-Effective Amendment No. 5”) to the Registration Statement on Form S-1 (File No. 333-250899) (the “Registration Statement”), as originally declared effective by the Securities and Exchange Commission (the “SEC”) on December 23, 2020, is being filed to include information contained in the registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023, which was filed with the SEC on March 13, 2024, the registrant’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2024, which was filed with the SEC on May 17, 2024, and to update the selling stockholder table and certain other information in the Registration Statement.No additional securities are being registered under this Post-Effective Amendment No. 5. All applicable registration fees were paid at the time of the original filing of the Registration Statement on December 15, 2020.
Entity Central Index Key 0001173313
Entity Filer Category Non-accelerated Filer
Entity Small Business true
Entity Emerging Growth Company false
Entity Incorporation, State or Country Code NV